Nuclear Activation Function 2 Estrogen Receptor α Attenuates Arterial and Renal Alterations Due to Aging and Hypertension in Female Mice

E. Guivarch1, Julie Favre1, Anne‐Laure Guihot1, Emilie Vessières1, Linda Grimaud1, C Proux1, J Rivron1, Agnès Barbelivien1, Céline Fassot1, Marie Briet1,2, Françoise Lenfant3, Coralie Fontaine3, Laurent Loufrani1, Jean‐François Arnal3, Daniel Henrion1,2
1MITOVASC Institute and CARFI Facility INSERM U1083 CNRS UMR 6015 Angers University Angers France
2University Hospital of Angers, Angers, France
3Institut des Maladies Métaboliques et Cardiovasculaires Université de Toulouse 3 UMR INSERM 1048 Toulouse France

Tóm tắt

Background The cardiovascular protective effects of estrogens in premenopausal women depend mainly on estrogen receptor α (ERα). ERα activates nuclear gene transcription regulation and membrane‐initiated signaling. The latter plays a key role in estrogen‐dependent activation of endothelial NO synthase. The goal of the present work was to determine the respective roles of the 2 ERα activities in endothelial function and cardiac and kidney damage in young and old female mice with hypertension, which is a major risk factor in postmenopausal women.

Methods and Results Five‐ and 18‐month‐old female mice lacking either ERα (ERα −/− ), the nuclear activating function AF2 of ERα (AF2°), or membrane‐located ERα (C451A) were treated with angiotensin II (0.5 mg/kg per day) for 1 month. Systolic blood pressure, left ventricle weight, vascular reactivity, and kidney function were then assessed. Angiotensin II increased systolic blood pressure, ventricle weight, and vascular contractility in ERα −/− and AF2° mice more than in wild‐type and C451A mice, independent of age. In both the aorta and mesenteric resistance arteries, angiotensin II and aging reduced endothelium‐dependent relaxation in all groups, but this effect was more pronounced in ERα −/− and AF2° than in the wild‐type and C451A mice. Kidney inflammation and oxidative stress, as well as blood urea and creatinine levels, were also more pronounced in old hypertensive ERα −/− and AF2° than in old hypertensive wild‐type and C451A mice.

Conclusions The nuclear ERα‐AF2 dependent function attenuates angiotensin II–dependent hypertension and protects target organs in aging mice, whereas membrane ERα signaling does not seem to play a role.

Từ khóa


Tài liệu tham khảo

10.1016/j.maturitas.2010.11.016

10.1152/physrev.00024.2016

10.1080/13697130902986385

10.1016/0735-1097(94)90305-0

10.1161/ATVBAHA.114.303404

10.1161/01.CIR.103.3.423

10.1073/pnas.042688499

10.1161/hh0402.105096

10.1016/j.vph.2011.06.003

10.1073/pnas.1322057111

10.1126/science.1112062

10.1172/JCI38291

10.1161/JAHA.118.008950

10.1073/pnas.1105632108

10.1042/CS20130407

10.1038/jhh.2013.55

10.1073/pnas.0712029105

10.1007/s11302-017-9597-9

10.1097/00004872-199602000-00005

10.1096/fj.01-0505fje

10.1161/01.ATV.0000118683.99628.42

10.1038/srep45625

10.1016/j.cardiores.2006.10.020

10.1161/CIRCRESAHA.115.306305

10.1161/ATVBAHA.108.182279

10.1152/physrev.00021.2015

10.1080/13697137.2016.1198574

10.1016/j.neubiorev.2010.07.002

10.1152/ajpregu.00231.2016

10.1152/ajprenal.00145.2002

10.1152/ajpheart.01011.2005

10.1161/JAHA.116.005204

10.1161/ATVBAHA.112.300334

Mulvany MJ. Small artery remodeling and significance in the development of hypertension. News Physiol Sci. 2002;17:105–109.

10.1093/eurheartj/ehm448

10.1152/physiol.00059.2013

10.1007/s11906-010-0150-2

10.1093/cvr/cvp236

10.1161/01.ATV.0000254684.80662.44

Lehoux S, Tronc F, Tedgui A. Mechanisms of blood flow‐induced vascular enlargement. Biorheology. 2002;39:319–324.

10.1093/cvr/cvm055

10.1152/ajpheart.00766.2001

10.1152/ajpheart.00986.2013

10.1016/S0146-0005(97)80003-1

10.1074/jbc.R110.191791

10.1161/ATVBAHA.109.191221

10.1152/ajpheart.00966.2002

10.1073/pnas.93.9.4108

10.1159/000363203

10.1111/j.1432-1033.1978.tb12045.x

10.7754/Clin.Lab.2016.160329

10.1007/s10439-012-0568-6

10.14814/phy2.12342

10.1161/HYPERTENSIONAHA.117.09175

10.1016/j.exger.2011.02.003

10.1016/S1550-8579(07)80009-X

10.1095/biolreprod24.4.784

10.1161/HYPERTENSIONAHA.118.11485

10.1161/CIR.0000000000000485

10.1152/ajprenal.00206.2017

10.1152/ajpregu.00246.2012

10.1161/HYPERTENSIONAHA.114.03512

10.1152/ajpheart.00630.2004

10.1016/S1550-8579(08)80004-6

10.15252/emmm.201404112

10.3233/BD-150210

10.1016/B978-0-12-416673-8.00004-6

10.1038/nrm.2016.122

10.1038/nrd1031

10.1016/j.ajpath.2013.03.010

10.1016/j.contraception.2016.08.018